Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Staar, Ophtec Address Panel’s Phakic IOL Endothelial Cell Loss Concerns

This article was originally published in The Gray Sheet

Executive Summary

FDA Ophthalmic Devices Panel concerns regarding endothelial cell loss associated with phakic intraocular lens implantation will delay review of Ophtec's Artisan phakic IOL by two months, the firm says

You may also be interested in...



Refractec Preparing For February Panel Review Of RF Presbyopia Treatment

Refractec expects FDA approval of its CK Blended Vision radio frequency procedure for presbyopia to increase its market opportunity by 18 mil. people

Refractec Preparing For February Panel Review Of RF Presbyopia Treatment

Refractec expects FDA approval of its CK Blended Vision radio frequency procedure for presbyopia to increase its market opportunity by 18 mil. people

Staar Warning Letter Presents Challenges For ICL Approval Timeline

Staar Surgical continues to anticipate approval for the Collamer ICL implantable contact lens by April, despite compliance issues raised in a Dec. 22 FDA warning letter

Related Content

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel